CASE REPORT
HIV-associated autoimmune blistering and connective tissue disorders: a case report
 
More details
Hide details
1
Department of Infectious Diseases, Fattouma Bourguiba University Hospital, Monastir, Tunisia
 
2
Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
 
3
Department of Dermatology, Fattouma Bourguiba University Hospital, Monastir, Tunisia
 
 
Submission date: 2022-03-12
 
 
Final revision date: 2022-03-31
 
 
Acceptance date: 2022-03-31
 
 
Publication date: 2023-11-15
 
 
HIV & AIDS Review 2023;22(4):356-359
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
The association of human immunodeficiency virus (HIV) infection with the development of autoimmune disorders or systemic diseases is intriguing. Here, we describe a case of HIV-positive individual, who developed a bullous pemphigoid with several autoimmune disorders.

Case description:
A 58 year-old man was admitted to infectious diseases department in June, 2020 due to fever and blistering skin lesions. After several investigations, diagnosis of HIV infection and nodal tuberculosis as opportunistic infection, associated with a bullous pemphigoid was made. Topi­cal corticosteroids and anti-tuberculosis therapy began in June, 2020. Antiretroviral therapy started in August, 2020, with a good virological response. Four months later, in December 2020, the patient developed polyarthralgia and bilateral episcleritis. Testing for anti-nuclear antibodies and rheumatoid factors were positive. Autoimmune diseases were suspected, and the patient was treated with oral corticosteroids for two months with favorable outcome. However, in July, 2021, after the end of corticotherapy, clinical signs reappeared and the patient died of an acute kidney failure.

Conclusions:
Pathophysiology of autoimmune diseases in HIV population remains uncertain. There are several issues that need further studies regarding therapy, especially when systemic corticosteroids and immunosuppressive drugs are under consideration.

 
REFERENCES (10)
1.
Filippidis P, Comte D. Autoimmune disorders during chronic human immunodeficiency virus (HIV) infection. Rev Med Suisse 2019; 15: 723-731.
 
2.
Lebrun D, Hentzien M, Cuzin L, et al. Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort. AIDS 2017; 31: 2159-2166.
 
3.
Yen YF, Chuang PH, Jen IA, et al. Incidence of autoimmune diseases in a nationwide HIV/AIDS patient cohort in Taiwan, 2000-2012. Ann Rheum Dis 2016; 76: 661-665.
 
4.
Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 2002; 1: 329-337.
 
5.
Min MS, Damstetter E, Chen AYY. Autoimmune blistering disorders in the setting of human immunodeficiency virus infection. Int J Womens Dermatol 2018; 4: 159-165.
 
6.
Levy PM, Balavoine JF, Salomon D, Merot Y, Saurat JH. Ritodrine-responsive bullous pemphigoid in a patient with AIDS-related complex. Br J Dermatol 1986; 114: 635-636.
 
7.
Bull RH, Fallowfield ME, Marsden RA. Autoimmune blistering diseases associated with HIV infection. Clin Exp Dermatol 1994; 19: 47-50.
 
8.
De D, Kanwar AJ, Radotra BD, Narang T. Bullous eruption in a patient infected with the human immunodeficiency virus. Skinmed 2008; 7: 98-101.
 
9.
Braiteh N, Yacoub AT, Alchalabi S, Solis R, Kumar N, Fenlon C. A rare skin manifestation in a patient with human immunodeficiency virus: a case report and review of the literature. J Med Cases 2017; 8: 347-350.
 
10.
Vega LE, Espinoza LR. HIV infection and its effects on the development of autoimmune disorders. Pharmacol Res 2018; 129: 1-9.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top